Drechsler Andrew T 4
4 · Provention Bio, Inc. · Filed Jun 25, 2019
Insider Transaction Report
Form 4
Drechsler Andrew T
Chief Financial Officer
Transactions
- Award
Option (right to buy)
2019-06-24+400,000→ 400,000 totalExercise: $12.54Exp: 2029-06-24→ Common Stock, par value $0.0001 (400,000 underlying)
Footnotes (2)
- [F1]160,000 option shares vest in four equal annual installments commencing on June 24, 2020; the remaining 240,000 options shares vest upon completion of certain performance milestones. The completion of each milestone vests 20% of the total option shares.
- [F2]The securities were granted pursuant to the Issuer's Amended and Restated 2017 Equity Incentive Plan.